PRESS RELEASEView printer-friendly version << Back
WNS Launches PRECIZON to Deliver Cloud-based Competitive Intelligence for Life Sciences Industry
PRECIZON is customizable, scalable and easy-to-use, powered by WNS’ deep Pharma expertise and state-of-the-art Artificial Intelligence (AI) / Machine Learning (ML) models contextualized to CI needs. The robust AI / ML layer enables intelligence across the platform by collecting user-centric content and driving engagement. PRECIZON leverages complex search algorithms to evaluate the market landscape and drug approval timelines of competitors, providing Pharma companies with intelligent recommendations and unique views of the competitive landscape.
“Access to accurate, broad-based data sources and relevant analytical insights can give pharma companies a strategic advantage as they adapt to a complex market landscape, pricing pressures and evolving customer expectations. PRECIZON allows companies to prioritize R&D spends with a 360-degree real-time view shaped by agility, intelligent search algorithms, modularity and easy enterprise-wide access,” said
The platform is customizable for personalized reporting, easily integrated with existing commercial data and BI tools, and accessible across devices.
Safe Harbor Provision
This document includes information which may constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the accuracy of which are necessarily subject to risks, uncertainties, and assumptions as to future events. Factors that could cause actual results to differ materially from those expressed or implied are discussed in our most recent Form 20-F and other filings with the
EVP–Finance & Head of Investor Relations
+1 (646) 908-2615
Global Head –
+91 (22) 4095 2397
email@example.com ; firstname.lastname@example.org